Therapeutic Equivalence Evaluations Would Be Required For 505(b)(2) Drugs Under Senate User Fee Bill

 
• By Brenda Sandburg
Equivalence
FDA would have to provide therapeutic equivalence codes for certain generics under Senate user fee bill • Source: Shutterstock

More from User Fees

More from Pathways & Standards